News >

Challenges Continue With Lung Cancer Screening

Caroline Seymour
Published: Wednesday, Mar 28, 2018

M. Patricia Rivera, MD

M. Patricia Rivera, MD
Screening with low-dose CT has been shown to reduce mortality from lung cancer, but increased awareness of the benefits of screening and more clarity as to which individuals should be considered for it will prompt more widespread use in clinical practice, says M. Patricia Rivera, MD.

“If lung cancer screening is implemented correctly, it is my opinion that screening is the one intervention that is likely to have the most significant impact in lung cancer mortality, aside from surgery, chemotherapy, and targeted therapy,” said Rivera.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: IPF Best Practice: Evolving Paradigms in the Management of Idiopathic Pulmonary Fibrosis: Optimizing Outcomes Through a Team ApproachOct 31, 20191.0
Medical Crossfire®: Cystic Fibrosis-Related Diabetes (CFRD): A Patient-Focused Approach to Early Recognition and Proper TreatmentDec 31, 20191.5
Publication Bottom Border
Border Publication